Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer’s disease on Aβ1-40 peptide early assembly
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-2650
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer’s disease on Aβ1-40 peptide early assembly ; volume:411 ; number:24 ; day:12 ; month:8 ; year:2019 ; pages:6353-6363 ; date:9.2019
Analytical and bioanalytical chemistry ; 411, Heft 24 (12.8.2019), 6353-6363, 9.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00216-019-02030-7
- URN
-
urn:nbn:de:101:1-2020011512244072110328
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lazzaro, Serena
- Ogrinc, Nina
- Lamont, Lieke
- Vecchio, Graziella
- Pappalardo, Giuseppe
- Heeren, Ron M.A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum